Jinhe Biotechnology CO., LTD. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on May 12, 2022.

Jinhe Biotechnology CO., LTD. (SZSE:002688) commences share repurchases on May 25, 2022, under the program mandated by the shareholders in the Annual General Meeting held on May 12, 2022. As per the mandate, the company is authorized to repurchase up to CNY 200 million worth of its Class A shares. The repurchased shares will be used for Equity Incentive Plan.